Vertex Treatment May Have High Risk of Failure, Analyst Suggests By: Benzinga via Benzinga March 24, 2015 at 15:13 PM EDT Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) recent results from a prospective cystic fibrosis treatment suggests the product has ... Read More >> Related Stocks: Vertex Pharmaceuticals